Breast Cancer Trial, Recruiting (NCT05466786)

Breast Cancer Trial, Recruiting NCT05466786 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05466786 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a woman between 18 and 70 years old with breast cancer that has been confirmed by lab testing to be "HER2-low" (a specific level of a protein called HER2 in the tumor)
Your general health and ability to carry out daily activities is at a good or near-good level (confirm with trial site)
Your breast cancer has not been treated yet and can be operated on, and a specific genetic test called an HRD assessment has already been completed on your tumor
Your cancer has not spread to other parts of the body
There is enough tumor tissue and blood available from you to be used for research testing

Who may not be able to join:

Your breast cancer has come back after previous treatment, or it cannot be removed with surgery
You have cancer in both breasts
You have been diagnosed with another type of cancer within the last 5 years
Your medical or lab records are incomplete

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gong Chang, doctor, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phone: 02034070499

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05466786

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 02034070499

More information: https://clinicaltrials.gov/study/NCT05466786

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a woman between 18 and 70 years old with breast cancer that has been confirmed by lab testing to be "HER2-low" (a specific level of a protein called HER2 in the tumor)
Your general health and ability to carry out daily activities is at a good or near-good level (confirm with trial site)
Your breast cancer has not been treated yet and can be operated on, and a specific genetic test called an HRD assessment has already been completed on your tumor
Your cancer has not spread to other parts of the body
There is enough tumor tissue and blood available from you to be used for research testing

Who may not be able to join:

Your breast cancer has come back after previous treatment, or it cannot be removed with surgery
You have cancer in both breasts
You have been diagnosed with another type of cancer within the last 5 years
Your medical or lab records are incomplete

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Registry

ClinicalTrials.gov

Start date

7 August 2022

Est. completion

31 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

1.To assess the distribution characteristics of mHRR/HRD in breast cancer with low HRE2 expression in Chinese population

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov